help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chopra, S.
Right arrow Articles by Cohen, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chopra, S.
Right arrow Articles by Cohen, A. S.

American Journal of Pathology, Vol 115, 186-193, Copyright © 1984 by American Society for Investigative Pathology


REGULAR ARTICLES

Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms

S Chopra, A Rubinow, RS Koff and AS Cohen

The liver is a major site of amyloid deposition. The spectrum of histopathologic changes in the liver was studied in 38 patients with systemic amyloidosis (25 with primary or myeloma-associated amyloidosis [AL] and 13 with secondary, reactive [AA] amyloidosis). Overall architectural distortion, alterations of portal triads, as well as predilection for topographic deposition in the parenchyma and/or blood vessel walls were noted. Significant histopathologic differences in AL or AA amyloid liver involvement included 1) portal fibrosis, seen in 7 of 25 (28%) AL patients and 8 of 13 (62%) AA patients (P = 0.05), 2) parenchymal amyloid deposition in 25 of 25 (100%) AL amyloid and 10 of 13 (77%) AA amyloid patients (P = 0.04), and 3) vascular amyloid deposition found in 17 of 25 (68%) with AL amyloid and 13 of 13 (100%) patients with AA amyloid (P = 0.02). These data vary from the widely held concept that deposition of amyloid is predominantly vascular in the AL form and parenchymal in amyloid AA. Clearly, however, in individual cases significant overlap occurred, and characterization of amyloid types based on morphologic distribution of amyloid deposits may be possible in only a minority of cases. In most cases, differentiation of amyloid AL and amyloid AA forms requires clinical, histochemical, immunochemical, and sometimes more elaborate laboratory amino acid sequence studies for accurate identification.


This article has been cited by other articles:


Home page
CirculationHome page
R. H. Falk
Diagnosis and Management of the Cardiac Amyloidoses
Circulation, September 27, 2005; 112(13): 2047 - 2060.
[Full Text] [PDF]


Home page
GutHome page
L B Lovat, M R Persey, S Madhoo, M B Pepys, and P N Hawkins
The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients
Gut, May 1, 1998; 42(5): 727 - 734.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
M. G. Haddad, J. F. Silverman, E. W. Larkin, and M. Dellasega
Initial Diagnosis of Unsuspected Primary Amyloidosis (AL) by Liver Biopsy
International Journal of Surgical Pathology, July 1, 1993; 1(1): 57 - 63.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Society for Investigative Pathology.